疑似大血管闭塞卒中患者的转运策略建模
该理论研究利用卒中临床试验数据建立条件概率模型,比较直接转运至血管内治疗中心(mothership)与立即阿替普酶治疗后转运(drip and ship)两种策略的预后概率。结果显示,两中心相距60分钟或以内且治疗时间最优时两种策略预后相似;随着转运时间增至90或120分钟,若患者需经过溶栓中心或到达血管内治疗中心时超出阿替普酶治疗时间窗,则drip and ship更优;溶栓中心治疗时间慢或筛查工具阳性预测值高时,mothership优势区域扩大。作者认为转运决策具有情境特异性,基于当前中位治疗时间,血管内治疗应在区域层面集中化。
要点
- 两中心相距60分钟或以内且治疗时间最优时,mothership与drip and ship估计的预后相似。
- 转运时间增至90或120分钟时,若患者需经过溶栓中心或到达血管内治疗中心时超出阿替普酶治疗时间窗,则drip and ship更优。
- 溶栓中心治疗时间慢或筛查工具阳性预测值高时,mothership估计最佳预后的区域扩大。
核心结论
- 该研究提示,可利用现有临床试验数据对院前转运决策进行建模,且模型可动态适应变化的情境。
- 基于当前实现血管内治疗全部获益的中位治疗时间,研究结果提示该治疗应在区域层面集中化。
- 研究建模提示转运决策具有情境特异性,转运策略的优势半径随两中心治疗时间、转运时间和分诊工具而变化。
研究设计与样本
- 理论研究,条件概率建模研究,利用现有卒中治疗临床试验数据生成模型,研究时间为2017年2月1日至2018年3月1日。
主要发现
- 患者从溶栓中心和血管内治疗中心出发的转运时间、治疗速度及筛查工具的阳性预测值影响drip and ship与mothership哪种策略估计预后最佳。
- 在最优治疗时间下(door-to-needle时间30分钟;door-in-door-out时间50分钟;door-to-groin-puncture时间mothership为60分钟、drip and ship为30分钟),两中心相距60分钟或以内时两种策略估计的预后相似。
- 随着两中心间转运时间增加(90或120分钟),若患者需经过溶栓中心才能到达血管内治疗中心,或患者在mothership情景下到达时超出阿替普酶治疗时间窗,则drip and ship更优。
- 保持其他变量不变,若溶栓中心治疗时间慢(door-to-needle时间60分钟;door-in-door-out时间120分钟),mothership估计最佳预后的区域扩大,尤其当两中心相距较近(60分钟或以内)时。
- mothership估计最佳预后的区域也随筛查工具阳性预测值的增加而扩大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Ischemic stroke with large-vessel occlusion can be treated with alteplase and/or endovascular therapy; however, the administration of each treatment is time sensitive. OBJECTIVE: To identify the optimal triage and transport strategy: direct to the endovascular center (mothership) or immediate alteplase treatment followed by transfer to the endovascular center (drip and ship), for all patients with suspected large-vessel occlusion stroke. DESIGN SETTING, AND PARTICIPANTS: This was a theoretical, conditional probability modeling study. Existing data from clinical trials of stroke treatment were used for model generation. The study was conducted from February 1, 2017, to March 1, 2018. MAIN OUTCOMES AND MEASURES: The time-dependent efficacy of alteplase and endovascular therapy and the accuracy of large-vessel occlusion screening tools were modeled to estimate the probability of positive outcome (modified Rankin Scale score, 0-1 at 90 days) for both the drip-and-ship and mothership transport strategies. Based from onset to treatment, the strategy that estimates the greatest probability of excellent outcome is determined in several different scenarios. RESULTS: The patient's travel time from both thrombolysis and endovascular therapy centers, speed of treatment, and positive predictive value of the screening tool affect whether the drip-and-ship or mothership strategy estimates best outcomes. With optimal treatment times (door-to-needle time: 30 minutes; door-in-door-out time: 50 minutes; door-to-groin-puncture time: 60 minutes [mothership], 30 minutes [drip and ship]), both options estimate similar outcomes when the centers are 60 minutes or less apart. However, with increasing travel time between the 2 centers (90 or 120 minutes), drip and ship is favored if the patient would have to travel past the thrombolysis center to reach the endovascular therapy center or if the patient would arrive outside the alteplase treatment time window in the mothership scenario. Holding other variables constant, if treatment times are slow at the thrombolysis center (door-to-needle time: 60 minutes; door-in-door-out time: 120 minutes), the area where mothership estimates the best outcomes expands, especially when the 2 centers are close together (60 minutes apart or less). The area where mothership estimates the best outcome also expands as the positive predictive value of the screening tool increases. CONCLUSIONS AND RELEVANCE: This study suggests that decision making for prehospital transport can be modeled using existing clinical trial data and that these models can be dynamically adapted to changing realities. Based on current median treatment times to realize the full benefit of endovascular therapy on a population level, the study findings suggest that delivery of the treatment should be regionally centralized. The study modeling suggests that transport decision making is context specific and the radius of superiority of the transport strategy changes based on treatment times at both centers, transport times, and the triaging tool used.
引用
- Holodinsky JK, Williamson TS, Demchuk AM, et al. Modeling Stroke Patient Transport for All Patients With Suspected Large-Vessel Occlusion. JAMA Neurol. 2018. PMID: 30193366. doi:10.1001/jamaneurol.2018.2424
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。